Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus Type 16 Infection”

108 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 108 results

Not applicableActive Not RecruitingNCT05669911
What this trial is testing

Development of a Self-collection Device for Cervical Cancer Screening

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Human Papilloma Virus
Teal Health, Inc. 235
Not applicableNot Yet RecruitingNCT07714577
What this trial is testing

Investigator-Initiated Study of BBM-C101 Injection in Subjects With HPV16/18 Infection

Who this might be right for
HPV16/18 Positive
Tianjin First Central Hospital 200
Testing effectiveness (Phase 2)Study completedNCT00339040
What this trial is testing

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 130
Post-approval studies (Phase 4)Looking for participantsNCT07668271
What this trial is testing

Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)

Who this might be right for
Infection by Human Papilloma Virus
Xiamen Innovax Biotech Co., Ltd 720
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Not applicableStudy completedNCT01694875
What this trial is testing

Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System

Who this might be right for
Human Papillomavirus Infection
Gen-Probe, Incorporated 2,200
Testing effectiveness (Phase 2)Study completedNCT00365378
What this trial is testing

Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)

Who this might be right for
HPV 16 Infection
Merck Sharp & Dohme LLC 2,409
Testing effectiveness (Phase 2)Study completedNCT04260126
What this trial is testing

Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC

Who this might be right for
Metastatic Head and Neck CancerRecurrent Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
PDS Biotechnology Corp. 95
Testing effectiveness (Phase 2)Ended earlyNCT03937791
What this trial is testing

Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Who this might be right for
Squamous Lntraepithelial Lesions of VulvaNeoplasms, Squamous CellVulvar HSIL
National Cancer Institute (NCI) 1
Large-scale testing (Phase 3)Study completedNCT00316706
What this trial is testing

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

Who this might be right for
Cervical Intraepithelial NeoplasiaPapillomavirus Infection
GlaxoSmithKline 1,245
Large-scale testing (Phase 3)Study completedNCT00834106
What this trial is testing

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC 3,006
Not applicableWithdrawnNCT01551537
What this trial is testing

Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka

Who this might be right for
Human Papillomavirus Infection
GlaxoSmithKline
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Large-scale testing (Phase 3)UnknownNCT06207175
What this trial is testing

Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 1,260
Testing effectiveness (Phase 2)Study completedNCT02740777
What this trial is testing

Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females

Who this might be right for
Human PapillomavirusCervical Intraepithelial NeoplasiaPersistent Infection
Shanghai Zerun Biotechnology Co.,Ltd 900
Not applicableLooking for participantsNCT07710703
What this trial is testing

NWRD09 for Persistent Cervical HPV16 Infection

Who this might be right for
Persistent Cervical HPV16 Infection
Newish Biotech (Wuxi) Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT00128661
What this trial is testing

Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants

Who this might be right for
Cervical CancerPrecancerous Condition
GlaxoSmithKline 7,466
Not applicableEnded earlyNCT01355003
What this trial is testing

GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 1,080
Large-scale testing (Phase 3)Study completedNCT00294047
What this trial is testing

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 5,752
Large-scale testing (Phase 3)Study completedNCT00325130
What this trial is testing

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 1,042
Next Page